ABBVIE INC
ABBV · NYSE
Updated at 2026-10-14 09:38:55
- Today's High
- $283.43
- Today’s Low
- $273.70
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $277.65
- Previous Close
- $281.12
- Volume
- 5.59M
- Market Cap
- $496.77B
- P/E Ratio
- 77.42X
- EPS
- $3.55
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, UNITED STATES, 60064-6400
- Country
- US
- Listing Date
- 2013-01-02
- Fiscal Year End
- December
- Shares Outstanding
- 1.76B
- CIK
- 0001551152
- Website
- www.abbvie.com
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Financial Metrics
Revenue
2026-06-30
$16.99B
2026-03-31
$15B
2025-12-31
$16.61B
2025-09-30
$15.77B
Operating Expenses
2026-06-30
$6.26B
2026-03-31
$6.05B
2025-12-31
$6.25B
2025-09-30
$8.56B
Net Income
2026-06-30
$3.61B
2026-03-31
$699M
2025-12-31
$1.81B
2025-09-30
$186M
Net Profit Margin
2026-06-30
21.26%
2026-03-31
4.65%
2025-12-31
10.92%
2025-09-30
1.17%
Earnings Per Share
2026-06-30
$3.65
2026-03-31
$2.65
2025-12-31
$2.71
2025-09-30
$1.86
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$8.6B
2026-03-31
$3.69B
2025-12-31
$5.36B
2025-09-30
$3.51B
Effective Tax Rate
2026-06-30
15.47%
2026-03-31
32.91%
2025-12-31
31.97%
2025-09-30
73.66%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $16.99B | $15B | $16.61B | $15.77B |
| Operating Expenses | $6.26B | $6.05B | $6.25B | $8.56B |
| Net Income | $3.61B | $699M | $1.81B | $186M |
| Net Profit Margin | 21.26% | 4.65% | 10.92% | 1.17% |
| Earnings Per Share | $3.65 | $2.65 | $2.71 | $1.86 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $8.6B | $3.69B | $5.36B | $3.51B |
| Effective Tax Rate | 15.47% | 32.91% | 31.97% | 73.66% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.